Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
NCT05781841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-07-23
Summary
Warts are common epidermal growths caused by various strains of human papilloma virus (HPV). Viral warts are common with a prevalence rate of 7-12%.
Human papilloma virus is small non enveloped viruses that contain a double-stranded DNA genome. There are more than 200 HPV genotypes are reported, however, the high-risk types, including HPV genotype-16 (HPV16), 18, 31, and 45, are the causes of 80% of cervical cancers.
Conditions
- Warts
Interventions
- DIAGNOSTIC_TEST
-
Detection of expression of SOCS3 gene
Detection of expression of SOCS3, in each samples using Real-Time PCR
- DIAGNOSTIC_TEST
-
Detection of expression of IFN-α gene
Detection of expression of IFN-α gene in each samples using Real-Time PCR
- DIAGNOSTIC_TEST
-
Detection of expression of IFN-β gene
Detection of expression of IFN-β gene in each samples using Real-Time PCR
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Hanan A Assaf, professor · Sohag University
-
Zeinab A Goda, lecturer · Sohag University
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-15
- Primary Completion
- 2023-09-30
- Completion
- 2023-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
NCT05761002 ·Status: UNKNOWN ·Phase: NA
-
Sclerotherapy and Candida Antigen in Treatment of Common Warts
NCT06749665 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gardasil Versus Cervarix in the Treatment of Warts
NCT05383625 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
NCT02750202 ·Status: COMPLETED ·Phase: PHASE3
-
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
NCT04814446 ·Status: RECRUITING ·Phase: PHASE3
-
Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts
NCT05326152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
NCT00114920 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
NCT05026138 ·Status: RECRUITING
-
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts
NCT03183765 ·Status: COMPLETED ·Phase: PHASE4
-
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
NCT01598779 ·Status: COMPLETED
-
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
NCT01532102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
NCT01192282 ·Status: COMPLETED
-
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
NCT00115141 ·Status: COMPLETED ·Phase: PHASE2
-
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts
NCT05300009 ·Status: UNKNOWN ·Phase: NA
-
Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
NCT00499967 ·Status: COMPLETED ·Phase: PHASE1
-
Intralesional Treatment of Plantar Wart
NCT05057663 ·Status: UNKNOWN ·Phase: NA
-
Triple Antigen vs Monoantigen Immunotherapy for Warts
NCT05254561 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison Between Intralesional Injection of Plasma Rich Platelets and Candida Antigen in Plane Warts
NCT05652998 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Plantar Warts
NCT05198180 ·Status: UNKNOWN ·Phase: PHASE3
-
A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts
NCT05146895 ·Status: UNKNOWN ·Phase: NA
-
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts
NCT03158168 ·Status: UNKNOWN ·Phase: PHASE3
-
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
NCT04399577 ·Status: COMPLETED ·Phase: PHASE2
-
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
NCT05616078 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
NCT02971891 ·Status: COMPLETED ·Phase: PHASE3